- Home
- RPRX vs PNR Comparison
RPRX vs PNR Comparison
Compare RPRX & PNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RPRX | PNR |
|---|---|---|
| Founded | 1996 | 1966 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.4B | 16.7B |
| IPO Year | 2020 | 2003 |
Fundamental Metrics
Financial Performance| Metric | RPRX | PNR |
|---|---|---|
| Price | $46.03 | $90.56 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 14 |
| Target Price | $47.75 | ★ $116.62 |
| AVG Volume (30 Days) | ★ 3.2M | 1.4M |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.07% | 1.17% |
| EPS Growth | N/A | ★ 5.88 |
| EPS | 1.78 | ★ 3.96 |
| Revenue | ★ $2,378,193,000.00 | N/A |
| Revenue This Year | $38.30 | $4.21 |
| Revenue Next Year | $4.80 | $4.60 |
| P/E Ratio | $25.56 | ★ $23.30 |
| Revenue Growth | ★ 5.06 | N/A |
| 52 Week Low | $29.66 | $74.25 |
| 52 Week High | $47.86 | $113.95 |
Technical Indicators
Market Signals| Indicator | RPRX | PNR |
|---|---|---|
| Relative Strength Index (RSI) | 61.06 | 27.85 |
| Support Level | $35.32 | N/A |
| Resistance Level | $46.14 | $108.26 |
| Average True Range (ATR) | 0.88 | 2.61 |
| MACD | -0.19 | -0.87 |
| Stochastic Oscillator | 43.64 | 13.00 |
Price Performance
Historical ComparisonAbout RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About PNR Pentair plc.
Pentair is a global leader in the water treatment industry, with 10,000 employees and a presence in 25 countries. Its business is organized into three segments: pool, water technologies, and flow. The company offers a wide range of water solutions, including energy-efficient swimming pool equipment, filtration solutions, and commercial and industrial pumps. Pentair generated approximately $4.2 billion in revenue in 2025.